Additionally, studies have shown that the Fyn/FAK/N-WASP pathway plays a crucial role in liver fibrosis, and inhibiting this pathway can provide significant benefits to patients with liver fibrosis [36]. The gene discussed is PTK2; the disease is Hepatic fibrosis.